Role of DNA methylation in lupus
DNA 甲基化在狼疮中的作用
基本信息
- 批准号:9206130
- 负责人:
- 金额:$ 38.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-02-25 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAffectAllelesAnimal ModelAutoimmune DiseasesBANK1 geneBLK geneBiological ProcessCD4 Positive T LymphocytesChromatinChronicCpG IslandsDNA MethylationDNA Modification MethylasesDNA ResequencingDNA biosynthesisDefectDiseaseDisease susceptibilityEnvironmentEnzymesEpigenetic ProcessEtiologyFlareFrequenciesGene ExpressionGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenetic TranscriptionGenetic studyGenomeHaplotypesHeritabilityHuman BiologyHuman GenomeIRAK1 geneIndividualInterferon Type IKnowledgeLiteratureLupusMaintenanceMediatingMethyl-CpG-Binding Protein 2MethylationMorbidity - disease ratePathogenesisPatientsPredispositionPromoter RegionsRecruitment ActivityRelapseReportingResolutionRiskRoleSiteSpecificitySusceptibility GeneSystemic Lupus ErythematosusT-LymphocyteT-Lymphocyte SubsetsTimeTranscriptional RegulationVariantWorkbody systemexperimental studyfallsgenetic associationgenetic variantgenome-widegenome-wide analysisinsightmortalitynext generation sequencingnovelnovel diagnosticspromoterpublic health relevancerisk variantsystemic autoimmune diseasetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Systemic lupus erythematosus is a chronic relapsing autoimmune disease that involves multiple organ systems. The etiology and pathogenesis of lupus are incompletely understood. There is a strong evidence for genetic contribution to the pathogenesis of lupus, however, despite the enormous progress in mapping lupus susceptibility genes, only a small fraction of lupus heritability is accounted for by the genetic associations discovered. A large body of literature supports the contention that epigenetic dysregulation, particularly T cell DNA methylation defect, contributes to the pathogenesis of lupus. Indeed, demethylated T cells are sufficient to cause lupus in animal models. We believe that epigenetic differences between lupus patients and controls contribute towards the "missing" heritability of the disease. We propose to determine and functionally characterize differentially methylated genetic loci in specific T cell subsets in lupus patients compared to normal controls, using a genome-wide approach, the feasibility of which has been confirmed in our own preliminary experiments. We will further Identify and validate DNA methylation changes over time in relation to disease activity in lupus patients. We hypothesize that genetic variants associated with lupus will alter DNA methylation in known lupus susceptibility loci in an allele-specific manner. Therefore, we will determine allele specific DNA methylation changes in validated genetic susceptibility loci for lupus. We previously reported the genetic association between SNPs within MECP2 and lupus. MECP2 (methyl-CpG-binding protein 2) is a key transcriptional regulator for methylation sensitive genes, and is also known to recruit the DNA methylation enzyme DNMT1 during DNA synthesis. We will resequence the MECP2/IRAK1 LD block using next generation sequencing to identify the causal variants in this locus.
描述(由申请人提供):系统性红斑狼疮是一种涉及多个器官系统的慢性复发性自身免疫性疾病。狼疮的病因和发病机制尚不完全清楚。有强有力的证据表明遗传对狼疮发病机制的贡献,然而,尽管在绘制狼疮易感基因图谱方面取得了巨大进展,但所发现的遗传关联仅解释了狼疮遗传性的一小部分。大量文献支持表观遗传失调,特别是 T 细胞 DNA 甲基化缺陷,导致狼疮发病机制的论点。事实上,去甲基化的 T 细胞足以在动物模型中引起狼疮。我们认为,狼疮患者和对照者之间的表观遗传差异导致了该疾病遗传性的“缺失”。我们建议使用全基因组方法来确定和功能性表征狼疮患者特定 T 细胞亚群中与正常对照相比的差异甲基化遗传位点,其可行性已在我们自己的初步实验中得到证实。我们将进一步识别和验证 DNA 甲基化随时间的变化与狼疮患者疾病活动的关系。我们假设与狼疮相关的遗传变异将以等位基因特异性方式改变已知狼疮易感位点的 DNA 甲基化。因此,我们将确定经验证的狼疮遗传易感性位点中等位基因特异性 DNA 甲基化变化。我们之前报道了 MECP2 内的 SNP 与狼疮之间的遗传关联。 MECP2(甲基-CpG 结合蛋白 2)是甲基化敏感基因的关键转录调节因子,并且还已知在 DNA 合成过程中招募 DNA 甲基化酶 DNMT1。我们将使用下一代测序对 MECP2/IRAK1 LD 块进行重新测序,以识别该基因座中的因果变异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amr H Sawalha其他文献
Amr H Sawalha的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amr H Sawalha', 18)}}的其他基金
Characterizing the Takayasu arteritis genetic risk in RPS9/LILRB3
RPS9/LILRB3 中大动脉炎遗传风险的表征
- 批准号:
10017651 - 财政年份:2019
- 资助金额:
$ 38.94万 - 项目类别:
Characterizing the Takayasu Arteritis Genetic Risk in RPS9/LILRB3
RPS9/LILRB3 中大动脉炎遗传风险的表征
- 批准号:
9308409 - 财政年份:2017
- 资助金额:
$ 38.94万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 38.94万 - 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 38.94万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 38.94万 - 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
- 批准号:
10735117 - 财政年份:2023
- 资助金额:
$ 38.94万 - 项目类别: